World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
44882
World Ranking
8475
National Ranking
830

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Mark Emberton is affiliated with University College London in the United Kingdom. Their research focuses primarily on the field of Medicine, with a notable emphasis on subfields such as Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Rheumatology, Surgery, and Biomedical Engineering.

The scientist's main topics of work include:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Radiomics and Machine Learning in Medical Imaging
  • Urologic and Reproductive Health Conditions
  • MRI in Cancer Diagnosis
  • Bladder and Urothelial Cancer Treatments
  • Advanced Radiotherapy Techniques

Mark Emberton has contributed to several frequent publication venues, highlighting a focus on urology and oncological imaging. These venues include:

  • European Urology
  • The Journal of Urology
  • British Journal of Urology
  • European Urology Open Science
  • arXiv (Cornell University)

Their frequent co-authors reflect a collaborative network centered on urological cancer research and imaging:

  • Caroline M. Moore
  • Alex Freeman
  • Shonit Punwani
  • Hashim U. Ahmed
  • Francesco Giganti

Recent papers authored or co-authored by Mark Emberton include:

  • "Early detection of cancer," 2022, Science
  • "Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial," 2020, European Urology Oncology
  • "Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study," 2020, European Urology
  • "Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience," 2022, European Urology
  • "TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now," 2020, Prostate Cancer and Prostatic Diseases

Mark Emberton has received recognition as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

    Hashim U Ahmed;Hashim U Ahmed;Ahmed El-Shater Bosaily;Ahmed El-Shater Bosaily;Louise C. Brown;Rhian Gabe

  • MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

    Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco

  • EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

    Matthias Oelke;Alexander Bachmann;Aurélien Descazeaud;Mark Emberton

  • Systematic review of complications of prostate biopsy.

    Stacy Loeb;Annelies Vellekoop;Hashim U. Ahmed;James Catto

  • Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting

    Louise Dickinson;Louise Dickinson;Louise Dickinson;Hashim U. Ahmed;Hashim U. Ahmed;Clare Allen;Jelle O. Barentsz

  • Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature

    Jurgen J. Fütterer;Alberto Briganti;Pieter De Visschere;Mark Emberton

  • EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

    Stephan Madersbacher;Gerasimos Alivizatos;Jorgen Nordling;Carlos Rioja Sanz

  • Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.

    Caroline M. Moore;Caroline M. Moore;Nicola L. Robertson;Nasr Arsanious;Thomas Middleton

  • Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review

    Massimo Valerio;Massimo Valerio;Massimo Valerio;Ian Donaldson;Mark Emberton;Mark Emberton;Behfar Ehdaie

  • How good is MRI at detecting and characterising cancer within the prostate

    Alexander P.S. Kirkham;Mark Emberton;Clare Allen

  • Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.

    Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton

  • Weakly-supervised convolutional neural networks for multimodal image registration.

    Yipeng Hu;Yipeng Hu;Marc Modat;Eli Gibson;Wenqi Li

  • Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study

    Hashim U Ahmed;Hashim U Ahmed;Richard G Hindley;Louise Dickinson;Louise Dickinson;Alex Freeman

  • Is it time to consider a role for MRI before prostate biopsy

    Hashim U. Ahmed;Alex Kirkham;Manit Arya;Rowland Illing

  • The role of focal therapy in the management of localised prostate cancer: a systematic review

    Massimo Valerio;Massimo Valerio;Hashim U Ahmed;Mark Emberton;Nathan L Lawrentschuk

  • Photodynamic therapy for prostate cancer—a review of current status and future promise

    Caroline M Moore;Doug Pendse;Mark Emberton

  • Benign prostatic hyperplasia: A progressive disease of aging men

    Mark Emberton;Gerald L Andriole;Jean de la Rosette;Bob Djavan

  • Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

    Abdel Rahmène Azzouzi;Sébastien Vincendeau;Eric Barret;Antony Cicco

  • Characterizing Clinically Significant Prostate Cancer Using Template Prostate Mapping Biopsy

    Hashim Uddin Ahmed;Yipeng Hu;Tim Carter;Nimalan Arumainayagam

  • New and Established Technology in Focal Ablation of the Prostate: A Systematic Review

    Massimo Valerio;Massimo Valerio;Massimo Valerio;Yannick Cerantola;Scott E. Eggener;Herbert Lepor

Frequent Co-Authors

Hashim U. Ahmed
Hashim U. Ahmed Imperial College Healthcare NHS Trust
Jan van der Meulen
Jan van der Meulen University of London
Dean C. Barratt
Dean C. Barratt University College London
David J. Hawkes
David J. Hawkes University College London
Chris Parker
Chris Parker Institute of Cancer Research
Arnauld Villers
Arnauld Villers University of Lille
Laurence Klotz
Laurence Klotz University of Toronto
Samir S. Taneja
Samir S. Taneja New York University
Susan A. Charman
Susan A. Charman Monash University
David Atkinson
David Atkinson University of Liverpool

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t have to follow a single path. Many students interested in healthcare may find alternative or supplementary degrees and career pathways that suit their goals or lifestyle. For those who are already registered nurses and want to advance, consider earning an rn to bsn online without clinicals—an option that provides flexibility and removes the requirement of in-person clinical experience.

If you aspire to reach the highest practice levels, pursuing a Doctor of Nursing Practice (DNP) is a popular route. Many professionals seek the fastest dnp program to quickly advance their careers, while others look for more affordable dnp programs that make higher education more attainable without compromising quality.

Another viable entry point into healthcare is becoming a Licensed Practical Nurse (LPN). Those eager to join the workforce sooner may be interested in a fast lpn program, which enables students to start their careers quickly through accelerated online coursework.

With these diverse online offerings, students can find a program that matches both their career ambitions and lifestyle needs, from entry-level nursing to advanced clinical practice.

Best Scientists Citing Mark Emberton

Trending Scientists